登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 143499 条符合本次的查询结果， 用时 8.5391477 秒

161. Allan Maleche: legal advocate for health justice and human rights.

作者: Aarathi Prasad.
来源: Lancet. 2024年403卷10434期1327页

162. Biosafety regulations are not yet fit for purpose.

作者: Talha Burki.
来源: Lancet. 2024年403卷10434期1325-1326页

163. Anti-LGBTQ+ laws in Africa harming health and research.

作者: Gilbert Nakweya.
来源: Lancet. 2024年403卷10434期1323-1324页

164. Retraction and republication-Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials.

作者: The Lancet Editors.
来源: Lancet. 2024年403卷10434期1321页

165. Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials.

作者: Qingyang Shi.;Yang Wang.;Qiukui Hao.;Per Olav Vandvik.;Gordon Guyatt.;Jing Li.;Zhe Chen.;Shishi Xu.;Yanjiao Shen.;Long Ge.;Feng Sun.;Ling Li.;Jiajie Yu.;Kailei Nong.;Xinyu Zou.;Siyi Zhu.;Cong Wang.;Shengzhao Zhang.;Zhi Qiao.;Zhongyu Jian.;Ya Li.;Xinyi Zhang.;Kerun Chen.;Furong Qu.;Yuan Wu.;Yazhou He.;Haoming Tian.;Sheyu Li.
来源: Lancet. 2024年403卷10434期e21-e31页
Pharmacotherapy provides an option for adults with overweight and obesity to reduce their bodyweight if lifestyle modifications fail. We summarised the latest evidence for the benefits and harms of weight-lowering drugs.

166. Severe reactivation of seronegative occult hepatitis B after chemotherapy for lymphoma.

作者: Harrys A Torres.;Khalis Mustafayev.;Loretta J Nastoupil.;Samuel A Shelburne.
来源: Lancet. 2024年403卷10434期1372-1373页

167. Department of Error.

来源: Lancet. 2024年403卷10434期1340页

168. Department of Error.

来源: Lancet. 2024年403卷10434期1340页

169. Department of Error.

来源: Lancet. 2024年403卷10434期1340页

170. High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.

作者: Leon Peto.;Buddha Basnyat.;Peter Horby.
来源: Lancet. 2024年403卷10434期1339-1340页

171. High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.

作者: Sangeeta Bhusal.;Sudeep Adhikari.
来源: Lancet. 2024年403卷10434期1339页

172. High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.

作者: Teluguakula Narasaraju.;Yazhini Ravi.;Colleen B Jonsson.;Vincent T K Chow.
来源: Lancet. 2024年403卷10434期1338-1339页

173. High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.

作者: Nin-Chieh Hsu.;Yasuharu Tokuda.
来源: Lancet. 2024年403卷10434期1338页

174. High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.

作者: Natalie McEvoy.;Jessica Lowry.;Aidan O'Dowd.;Gerard F Curley.;Fidelma Fitzpatrick.
来源: Lancet. 2024年403卷10434期1337页

175. High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.

作者: Zia Hashim.;Alok Nath.;Naresh Kumar Tripathy.
来源: Lancet. 2024年403卷10434期1337-1338页

176. Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan.

作者: Arne Søraas.;Sonja H Brunvoll.;Anders B Nygaard.;John Arne Dahl.;Giske Ursin.
来源: Lancet. 2024年403卷10434期1336页

177. Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan - Authors' reply.

作者: Xiaoying Gu.;Lixue Huang.;Hui Zhang.;Bin Cao.
来源: Lancet. 2024年403卷10434期1336-1337页

178. WHO-Lancet Global Series on health and the arts.

作者: Stephen Clift.;Arne Bathke.;Helena Daffern.;Christina Davies.;Katarzyna Grebosz-Haring.;Mette Kaasgaard.;J Matt McCrary.;George Musgrave.;Leonhard Thun-Hohenstein.
来源: Lancet. 2024年403卷10434期1335页

179. The combination of systemic corticosteroids and inhaled adrenaline for bronchiolitis.

作者: Ben Gelbart.;Frank Shann.
来源: Lancet. 2024年403卷10434期1335页

180. WHO should embrace tobacco harm reduction to save lives.

作者: Derek Yach.
来源: Lancet. 2024年403卷10434期1334-1335页
共有 143499 条符合本次的查询结果， 用时 8.5391477 秒